Low
₹41,209.81
High
₹41,469.99
Low
₹36,415.87
High
₹42,723.73
| Previous Close | ₹41,371.07 |
|---|---|
| Day's Range | ₹41,209.81 - ₹41,469.99 |
| Open | ₹41,223.66 |
| 52 Week Range | ₹36,415.87 - ₹42,723.73 |
| Volume | 91,36,400 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1443.00 | |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1269.00 | |
Healthcare |
| Hero MotoCorp Ltd. | 4901.80 | |
Automobile & Ancillaries |
| JSW Steel Ltd. | 1231.00 | |
Iron & Steel |
| Grasim Industries Ltd. | 3199.80 | |
Diversified |
| Oil & Natural Gas Corporation Ltd. | 243.80 | |
Crude Oil |
| Tata Power Company Ltd. | 376.85 | |
Power |
| Hindalco Industries Ltd. | 965.55 | |
Non - Ferrous Metals |
| Tata Motors Passenger Vehicles Ltd. | 332.25 | |
Automobile & Ancillaries |
| Nestle India Ltd. | 1468.50 | |
FMCG |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24026.15 | 26373.20 | 22182.55 |
| Nifty IT | 27582.95 | 40301.40 | 25699.10 |
| Nifty Next 50 | 71604.65 | 73141.05 | 59896.10 |
| NIFTY50 USD Index | 8724.1 | 10443.40 | 8132.40 |
| Nifty Bank | 57310.95 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62264.7 | 62909.55 | 52032.85 |
| Nifty 500 | 23129.9 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17872.75 | 17909.45 | 14804.55 |
| Nifty 100 | 25051.15 | 26975.15 | 22720.45 |
| Nifty FMCG | 49477.0 | 58485.05 | 45334.15 |
Dr. Reddy’s Laboratories has informed that certain batches of semaglutide were found to be out of specification due to an issue associated with the active pharmaceutical ingredient (API) used in the product. The company is investigating the root cause and taking appropriate measures to ensure product quality. Until the issue is resolved, commercial supplies of the product will be delayed for a certain period of time. There is no impact on patient safety or on the product's existing global regulatory filings. The company remain committed to ensuring reliable global supplies of this important metabolic therapy. The management of the Company will host a conference call on Thursday, July 9, 2026 at 16:30 – 17:00 IST 07:00 – 07:30 ET to discuss the topic and answer any questions from the participants. The Pre-register link to join is enclosed. The transcript of the conference call will be available on the Company’s website: www.drreddys.com.
The above information is a part of company’s filings submitted to BSE.
In continuation to letter dated April 27, 2023 and July 25, 2023, Shriram Finance has informed that the ESOP Allotment Committee in its meeting held today, Tuesday, July 7, 2026 has approved the allotment of 33,311 Equity Shares of face value of Rs 2 each fully paid-up to 63 employees of the Company who exercised the Fresh Stock Options under SFL ESOS 2023 (No.1). The details as required under Regulation 10 (c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 is enclosed. Pursuant to allotment of the Equity Shares, the paid-up share capital of the Company stands increased from Rs.470,58,30,256/- to Rs.470,58,96,878/-.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of SNXN30 index is ₹41371.07 as of 2026-07-09.
The total volume of SNXN30 index is 9136400.00 as of 2026-07-09.
The percentage change in value of SNXN30 index is 0.62% as of 2026-07-09.
The absolute increase in SNXN30 index value since the previous trading day is ₹254.27 as of 2026-07-09.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.